La nostra avventura ad #AIOM si è conclusa con il progetto #ATLAS: ✅ Piattaforma #atlante BiomarkerAtlas; ✅ È un progetto scientifico; ✅ Dal 2024 è una #fondazione 🙏🏼Grazie ai fondatori e a tutti i ricercatori con #ATLAS danno luce e speranza al futuro della ricerca ✨

9,000 oncologists attending the ESMO plenary… and they’re all vibing with joy to be there. (Okay, maybe it’s an AI-generated video — but the enthusiasm is real!) #ESMO2025 #Oncology #AIhumor #PlenaryVibes

find the error #Esmo25 #smokefree

The young teacher (on the left) and the old student (to be guessed)

Final Presidential Plenary session at #WCLC25 chaired by Drs. @IsaOpitz @DrJNaidoo

The future, the talent and the awareness that I am a little elderly. A beautiful presentation of @PrelajArsela at #WCLC25

Great #WCLC25 opening Ceremony with the amazing chairs @UmbertoMalapel1 @DrJNaidoo @NReguart @IsaOpitz !! Congrats on the success of this excellent meeting! @IASLC

I'm sure it will be a unique experience once again

Dr Silvia Novello presenting the ATLAS an important Italian project on testing Cancer Registry. Congratulations to founders and collaborators of this platform at #RomeLung25 @ABiomarkers @UmbertoMalapel1 @FabioPagni1 @sara_pilotto @galetta2 @giuliapasello

Very interesting and intense discussion on the role of neoadjuvant vs perioperative chemo-immunotherapy. There is still no definitive consensus, many questions remain open, but a new path is now fully achievable #RomeLung25

Eve of #RomeLung25 - catching up with friends from all over, ready to discuss, debate, learn from each other and work out new strategies for lung cancer! @marinagarassino @pompili_cecilia @galetta2 @HosseinBorghaei @Alfdoc2 @CecereFabiana @isla_dolores

Thanks Drs @StephenVLiu and Tina Cascone for the excellent #TexasLung25! Amazing meeting, discussions and great atmosphere! I enjoyed our session on biomarkers testing and MRD with good friends @drgandara @christine_lovly @PatelOncology @IDEOlogyHealth

🧬Synergy between research and clinical practice🔬 The ATLAS Foundation is also mentioned on @repubblica📝 Click on the following link to access the full article🔗 https://t.co/yutR1JglDs #WeAreAtlas @galetta2 | @UmbertoMalapel1

Congratulations Umberto! It is likely that this will be increasingly advantageous as the years go by (the work refers to 2021). Do you think that we can also transfer the data to early-stage disease?

A new start! Biomarkers Atlas is for an Italian project that addresses the community of oncologists but looks to patients with lung cancer to create a "concrete" photograph of a dynamic disease but known in more and more detail. Thanks to the friends Silvia Novello and

a great debate sparked by @fedcappuzzo speech in VIII Lung cancer conference in Bari

Excellent presentation on the most complex lung pathology:SCLC @StephenVLiu

Dr. @peters_solange with a grand overview of unresectable stage III NSCLC at VIII Conferenza Oncologia Polmonare. PACIFIC is our standard. Hard lessons with concurrent chemoradiation and immunotherapy with negative results from PACIFIC2 and CheckMate 73L (per press release).